Dose Escalation and Dose Expansion Study of RMC-6291 Monotherapy in Subjects With Advanced KRASG12C Mutant Solid Tumors
Revolution Medicines, Inc.
Revolution Medicines, Inc.
Alterome Therapeutics, Inc.
Elevation Oncology
Revolution Medicines, Inc.
Sumitomo Pharma America, Inc.
Revolution Medicines, Inc.
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Swedish Medical Center
AVEO Pharmaceuticals, Inc.